Cargando…
Effect of Immunosuppressive Therapy on the Occurrence of Atypical Hemolytic Uremic Syndrome in Renal Transplant Recipients
BACKGROUND: Atypical hemolytic uremic syndrome (aHUS), a rare thrombotic microangiopathy, is characterized by hemolytic anemia, thrombocytopenia, and acute renal failure. Caused by genetic mutations in the alternative complement cascade, aHUS often will culminate in end-stage renal disease and occas...
Autores principales: | Raina, Rupesh, Chauvin, Abigail, Fox, Kelli, Kesav, Natasha, Ascha, Mustafa, Vachharajani, Tushar J., Krishnappa, Vinod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248048/ https://www.ncbi.nlm.nih.gov/pubmed/30190449 http://dx.doi.org/10.12659/AOT.909781 |
Ejemplares similares
-
Pediatric Atypical Hemolytic Uremic Syndrome Advances
por: Raina, Rupesh, et al.
Publicado: (2021) -
Complement activation in atypical hemolytic uremic syndrome and
scleroderma renal crisis: a critical analysis of pathophysiology
por: Zuckerman, Roman, et al.
Publicado: (2018) -
Optimal management of atypical hemolytic uremic disease: challenges and solutions
por: Raina, Rupesh, et al.
Publicado: (2019) -
Anti-factor H antibody and its role in atypical hemolytic uremic syndrome
por: Raina, Rupesh, et al.
Publicado: (2022) -
Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011)